Company intelligence / Profile preview

Uptake Medical

San Jose, California, United Statesuptakemedical.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

Uptake Medical has developed Bronchoscopic Thermal Vapor Ablation (BTVA), a non-surgical, non-implant device-based therapy for severe emphysema and lung cancer. Clinical studies have shown that BTVA can improve pulmonary function and quality of life in patients with severe emphysema. The technology is CE-marked and commercially available outside the US but is not FDA-approved for use in the United States[1][8]. Multiple clinical trials are ongoing or planned to further evaluate efficacy and safety.

Therapeutic areas: PulmonologyOncology
Modalities: DeviceNon-pharmacological therapy (Vapor ablation)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

InterVapor

Commercial

Indications: severe emphysema, lung disease

Beyond the preview

Go deeper on Uptake Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uptake Medical.

Explore the full profile